A D Consultancy was formed to expand and exploit the discrete sales and marketing network in pharmaceutical sales and supply management that has been developed by its key personnel through years of on-the-ground experience of Far East trading.
Operating in English-speaking markets, its activities are based on close working relationships with major suppliers of plant and raw materials – partnerships underpinned by its principals holding consultancy contracts with several Chinese trading consortia to spearhead sales and development.
AD Consultancy senior personnel have wide knowledge of the sector, holding Accredited British Pharmaceutical qualifications. Previous work ranges through UK healthcare manufacturing management to sourcing and supplying consumables for European pharmaceutical companies, primarily from China. All are experienced in the fields of biochemistry, chemistry, or pharmaceuticals and have been producing materials and technological services for more than 10 years.
Key companies in the sector served by A D Consulting include Hong Kong Kangdisen Medical Co., Limited (KDSMED) and Wuhan Yuancheng Technology Development Ltd.
Kangdisen focuses on production and distribution of biologicals, peptides, hormone, medicines and health products in China, and technological service in pharmaceutical industry. Wuhan Yuancheng Technology is a leading supplier, specialising in fine chemicals, food additives, pharmaceuticals and intermediates. It produces more than 5000 products for the medical and retail sector throughout China.
The innovative products A D Consultancy are marketing include reusable and environmentally friendly HGH and insulin pen syringes/generic delivery devices, which have particular cost appeal to UK and NHS markets.